TABLE I.
Demographic and clinical characteristics of the subjects used in the current study.
| ID | Gender | Age at onset of deafness (years) | Age at Testing (years) | Duration of deafness before implantation (years) | Duration of CI use | Implant | Processing strategy | Etiology of deafness | Sites tested |
|---|---|---|---|---|---|---|---|---|---|
| S45 | M | 44 | 50 | 1 | 5 | CI24R(CS) | ACE | Head injury | 3–22 |
| S53 | F | 26 | 58 | 26 | 6 | CI24R(CS) | ACE | Unknown | 3–22 |
| S54 | F | 32 | 71 | 35 | 4 | CI24R(CS) | ACE | Ototoxicity | 3, 5–22 |
| S57 | F | 60 | 68 | 3 | 5 | CI24M | SPEAK | Fever/Ménière’s | 3–21 |
| S58 | F | 42 | 57 | 6 | 9 | CI24M | SPEAK | Autoimmune | 3–22 |
| S60 | M | 62 | 67 | 2 | 3 | CI24R(CS) | ACE | Hereditary | 3–22 |
| S64 | F | 50 | 59 | 1 | 8 | CI24M | SPEAK | Unknown | 3–22 |
| S65 | F | 35 | 38 | 1 | 2 | CI24R(CS) | ACE | Hereditary | 2–13, 15–22 |
| S67 | M | 59 | 65 | < 1 | 6 | CI24R(CS) | ACE | Hereditary | 1–5, 7–21 |
| S71 | M | 57 | 60 | < 1 | 3 | CI24R(CS) | ACE | Unknown | 2–7, 9–22 |
| S72 | F | 16 | 66 | 47 | 3 | CI24R(CS) | ACE | Enlarged vestibular aqueduct | 5–13, 15–22 |
| S73 | M | 50 | 64 | 12 | 2 | CI24R(CS) | ACE | Unknown | 4–22 |
| S74 | F | 61 | 66 | 2 | 3 | CI24R(CS) | ACE | Unknown | 3–22 |
| S75 | M | 53 | 58 | 2 | 3 | CI24R(CS) | ACE | Noise induced | 2–21 |